Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Boehmer

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Oncologist|July 21, 2021
Oncology Expanded Access and FDA's Project FacilitateBarbara Scepura, Mitchell Chan, Tamy Kim, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 5, 2023
Equitable Access to Clinical Trials: How Do We Achieve It?Ana Acuña-Villaorduña, Joaquina Celebre Baranda, Jessica Boehmer, et al.
JAMA Oncology|January 4, 2024
Review of Racial and Ethnic Representation of Participants Enrolled in Pediatric Clinical Trials of Oncology Drugs Conducted Through FDA Written RequestsLola A Fashoyin-Aje, Alemayehu Y Akalu, Jessica Boehmer, et al.
Cancer Discovery|December 2, 2022
Highlights of FDA Oncology Approvals in 2022: Tissue-Agnostic Indications, Dosage Optimization, and Diversity in Drug DevelopmentElizabeth S Duke, Michael J Fusco, Patrick DeMoss, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Oncologist|July 21, 2021
Oncology Expanded Access and FDA's Project FacilitateBarbara Scepura, Mitchell Chan, Tamy Kim, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 5, 2023
Equitable Access to Clinical Trials: How Do We Achieve It?Ana Acuña-Villaorduña, Joaquina Celebre Baranda, Jessica Boehmer, et al.
JAMA Oncology|January 4, 2024
Review of Racial and Ethnic Representation of Participants Enrolled in Pediatric Clinical Trials of Oncology Drugs Conducted Through FDA Written RequestsLola A Fashoyin-Aje, Alemayehu Y Akalu, Jessica Boehmer, et al.
Cancer Discovery|December 2, 2022
Highlights of FDA Oncology Approvals in 2022: Tissue-Agnostic Indications, Dosage Optimization, and Diversity in Drug DevelopmentElizabeth S Duke, Michael J Fusco, Patrick DeMoss, et al.
Pageof 1